限制单胺降解会增加L-DOPA在新生小鼠的前驱动作用
Inès Khsime1, Marie Boulain1, Abderrahman Fettah1
1Univ. Bordeaux, CNRS, INCIA, UMR5287, F-33000 Bordeaux, France.
International journal of molecular sciences
|October 14, 2023
概括
抑制单胺降解增强了L-DOPAPA的作用.
科学领域:
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 利沃多巴 (Levodopa) 是甲基醇胺的前体,促进脊椎动物的运动.
- 产后早期的发育包括关键的单氨基胺系统的成熟.
- 了解增强L-DOPA亲运动效应的因素对于发育神经科学至关重要.
研究的目的:
- 调查抑制单胺降解是否可以在五天大的老鼠中增强低剂量的L-DOPA的亲运动作用.
- 确定单胺氧化酶 (MAO) 和甲基转移酶 (COMT) 抑制在调节L-DOPA诱导运动中的作用.
- 为了将脊髓单胺水平的生物化学变化与观察到的运动运动活动相关联.
主要方法:
- 给给五天大老老鼠的尼拉胺 (MAO抑制剂) 或托尔卡 (COMT抑制剂).
- 通过测量带中的空气步进序列来评估运动运动活动.
- 在部和腰部脊髓组织中的量化单胺和代谢物水平.
主要成果:
- 单独的尼亚胺和托尔卡都没有诱导显著的运动.
- 尼亚胺 (100 mg/kg) 和托尔卡 (100 mg/kg) 在与低效的L-DOPA剂量 (25 mg/kg) 同时服用时,最大限度地增强了空气循环.
- 通过脊髓内特定单胺水平的区域变化,证实了抑制剂的有效性.
结论:
- 抑制单胺的降解显著增强了年轻大鼠中低剂量L-DOPA的亲运动效应.
- 不同的单胺环境,通过明显的酶抑制来实现,可以导致最大的运动器反应.
- 这表明调节单胺代谢是一种可行的策略,可以提高L-DOPA在发育背景下的治疗潜力.
相关概念视频
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
01:24Parkinson's Disease: Treatment
283
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
283
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
354
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
354
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
173
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
173